Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

The first study of the personal, social and economic consequences of tuberculosis. A brilliant, wittily scarifying contribution to the history of ill-health.

This work contains updated and clinically relevant information about tuberculosis. It is aimed at providing a succinct overview of history and disease epidemiology, clinical presentation and the most recent scientific developments in the field of tuberculosis research, with an emphasis on diagnosis and treatment. It may serve as a practical resource for students, clinicians and researchers who work in the field of infectious diseases.

The victims of tuberculosis (usually known as consumption) included not only Keats, The Brontës, Chopin and Chekhov, but members of almost every family. It was a killer on a huge scale. The White Death is an outstanding history of tuberculosis. Thomas Dormandy's engrossing account of the search for a cure is complemented by a description of its complex natural history and by portraits of individual sufferers, including writers, artists, and musicians, whose lives and work were shaped (and often tragically curtailed) by the disease. But, tuberculosis is not just a disease of the past. In many parts of the world it is still a bigger killer than AIDS, while in America and Europe drug-resistant strains threaten its resurgence.

Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.